Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch Automation brings you the latest, most pertinent content at record speed and with ...
CAH expects specialty revenues to top $50B in FY26 as its expanding MSO and biopharma services ecosystem helps drive projected EPS growth of 23-26%.
DSCSA is in maintenance mode, but the National Drug Code promises to disrupt the industry with the move from 10-12 digits.
Market OverviewThe digital pharmaceutical supply chain management market is projected to expand at a compound annual growth rate (CAGR) of approximately 9% between 2025 and 2030, reflecting the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results